and Roskilde (Denmark). As a result, DUP in the early detection area was reduced from 26 weeks median to 4 weeks median. All patients with First Episode Psychosis in the early detection area have been followed for ten years, and a twenty-year follow-up is to take place shortly. Symptom and function advantages of early detection and DUP reduction have been demonstrated as being significant throughout the follow-up period. Social and functional outcome have been increasingly emphasized as being key parameters, as these contribute to both quality of life and to financial costs in society. Substance use is common in first-episode psychosis (FEP) and has been linked to poorer outcomes with more severe psychopathology and higher relapse rates. Early substance discontinuation appears to improve symptoms and function. However, studies vary widely in their methodology, and few have examined patients longitudinally, making it difficult to draw conclusions for practice and treatment. Methods: We aimed to investigate the relationship between substance use and early abstinence and the long-term course of illness in a representative sample of FEP patients. Out of 301 included patients, 266 could be divided into four groups based on substance use patterns during the first two years of treatment: persistent users, episodic users, stop-users and non-users. Differences in clinical and functional during the follow-up period were assessed using linear mixed effects (lme) models for the analysis of repeated measures data. Results: Patients who stopped using substances within the first two years after diagnosis had outcomes similar to those who had never used with less symptoms than episodic or persistent users. Both episodic and persistent users had lower rates of symptom remission than non-users, and persistent users also had more negative symptoms than those who stopped using. Discussion: Our findings emerge from one of very few long-term longitudinal studies examining substance use cessation in FEP with 10-year followup. The results convey hope that the detrimental effects of substance abuse on mental health may be significantly reversed if one stops the abuse in time. This can help patients who struggle with addiction with their motivation to embrace abstinence. Background: Long-term use of cannabis has long been associated with changes in cognition, including memory and learning, particularly verbal learning in man. However, evidence regarding the neurobiological underpinnings of impairments in memory following long-term cannabis use has not been consistent. Furthermore, to our knowledge none of the studies published to date have specifically investigated whether brain function differed between cannabis users and non-users while learning new information as estimated over repeated trials. Therefore, we aimed to investigate this. Methods: Twenty-one predominantly cannabis users (CU) who started using cannabis during adolescence and 21 healthy non-using controls (NU), completed a block design verbal paired associates learning task whilst undergoing functional Magnetic Resonance Imaging. The task required participants to learn and recall a set of word-pairs over 4 repeated trials. We examined the interaction between repetition and group (CU vs NU) on brain activation during encoding and recall condition using nonparametric repeated measures analysis of variance.
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T99. LONG-TERM CANNABIS USE ASSOCIATED
Results: There was no significant difference in total recall score between CU and NU. However, there was a significant effect of repetition (p<0.001) on recall score, suggesting that there was a significant improvement in recall score over repeated trials across the two groups of participants. Furthermore, there was a significant interaction between repetition and group on recall score such that the change in recall score over repeated trials significantly differed (p =0.032) between the CU and NU groups. This was associated with a significant interaction (p =0.009) between group and repetition on activation in the midbrain bilaterally, extending to the, parahippocampus, caudate and cingulate gyrus during the encoding condition. There was greater engagement of these regions in CU than in NU over repeated encoding trials. Discussion: These results suggest that verbal learning is slower and more effortful requiring greater engagement of critical brain areas involved in learning in cannabis users compared to non-users. 
T100. NICOTINE USE IMPACTS NEGATIVE
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Background: Advances in molecular biology, genetics and neuroimaging have the potential to improve our understanding of psychotic disorders.
